Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis.

Jie He, Monica A Thomas, Jaime de Anda, Michelle W Lee, Emma Van Why, Pippa Simpson, Gerard C L Wong, Mitchell H Grayson, Brian F Volkman, Anna R Huppler

Antimicrobial agents and chemotherapy 2020 Jul 22

filter terms:

Candida albicans is a commensal organism that causes life-threatening or life-altering opportunistic infections. Treatment of Candida infections is limited by the paucity of antifungal drug classes. Naturally occurring antimicrobial peptides are promising agents for drug development. CCL28 is a CC chemokine that is abundant in saliva and has in vitro antimicrobial activity. In this study, we examine the in vivo Candida killing capacity of CCL28 in oropharyngeal candidiasis as well as the spectrum and mechanism of anti-Candida activity. In the mouse model of oropharyngeal candidiasis, application of wild-type CCL28 reduces oral fungal burden in severely immunodeficient mice without causing excessive inflammation or altering tissue neutrophil recruitment. CCL28 is effective against multiple clinical strains of C. albicans Polyamine protein transporters are not required for CCL28 anti-Candida activity. Both structured and unstructured CCL28 proteins show rapid and sustained fungicidal activity that is superior to that of clinical antifungal agents. Application of wild-type CCL28 to C. albicans results in membrane disruption as measured by solute movement, enzyme leakage, and induction of negative Gaussian curvature on model membranes. Membrane disruption is reduced in CCL28 lacking the functional C-terminal tail. Our results strongly suggest that CCL28 can exert antifungal activity in part via membrane permeation and has potential for development as an anti-Candida therapeutic agent without inflammatory side effects. Copyright © 2020 American Society for Microbiology.

Citation

Jie He, Monica A Thomas, Jaime de Anda, Michelle W Lee, Emma Van Why, Pippa Simpson, Gerard C L Wong, Mitchell H Grayson, Brian F Volkman, Anna R Huppler. Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis. Antimicrobial agents and chemotherapy. 2020 Jul 22;64(8)